Does prehospital thrombolysis increase the proportion of patients who have an aborted myocardial infarction?

L Jackson1, J Kendall, N Castle

  • 1Emergency Department, Bristol Royal Infirmary, Bristol, UK. lornaj@doctors.org.uk

Insights

Prehospital thrombolysis reduced treatment times for acute coronary syndromes but did not increase the rate of aborted myocardial infarction. Further research is needed to understand why this intervention did not improve outcomes in the UK setting.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Clinical Trials

Background:

  • An aborted myocardial infarction involves rapid ST segment resolution with minimal cardiac enzyme elevation.
  • Previous studies indicate earlier thrombolysis correlates with higher rates of aborted infarction.
  • Prehospital thrombolysis is known to decrease the time from symptom onset to treatment.

Purpose of the Study:

  • To investigate if prehospital thrombolysis leads to a higher incidence of aborted myocardial infarction in the UK.
  • To compare outcomes between prehospital and in-hospital thrombolysis administration.

Main Methods:

  • Retrospective analysis of patients receiving prehospital or in-hospital thrombolysis (April 2004 - October 2006).
  • Data collected included troponin levels, call-to-needle, pain-to-needle, and door-to-needle times.
  • Comparison of aborted myocardial infarction incidence between prehospital and in-hospital groups.

Main Results:

  • Prehospital thrombolysis significantly reduced pain-to-needle time (69% ≤ 2 hours vs. 40.4%).
  • The overall incidence of aborted infarction was 16.5%.
  • No significant difference in aborted myocardial infarction rates was observed between prehospital (11.8%) and in-hospital (18.2%) thrombolysis groups (p=0.124).

Conclusions:

  • While prehospital thrombolysis shortened treatment times, it did not increase the proportion of aborted myocardial infarctions.
  • This finding contrasts with expectations and warrants further investigation.
  • Understanding the reasons for the lack of improved outcomes in the UK setting is crucial.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...